{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-026697","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.937298+00:00","generated_at":"2026-05-16T14:05:21.808019+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Immix Biopharma raises ~$93.7M net via 19.1M share and warrant offering at $5.10","bullets":["19,117,646 shares at $5.10/share and 490,196 pre-funded warrants at $5.09/warrant in underwritten offering.","Net proceeds expected ~$93.7M after underwriting discounts and estimated expenses.","Underwriting agreement with Morgan Stanley & Co. LLC as representative of underwriters.","Offering expected to close December 9, 2025, subject to customary closing conditions.","Pre-funded warrants exercisable immediately at $0.01/share, with 4.99% beneficial ownership limitation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-026697","json":"https://secwatch.observer/filing/0001493152-25-026697.json","markdown":"https://secwatch.observer/filing/0001493152-25-026697.md","text":"https://secwatch.observer/filing/0001493152-25-026697.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225026697/0001493152-25-026697-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225026697/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:05:21.808019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}